Management of community-acquired pneumonia in adults

Grant W. Waterer, Jordi Rello, Richard G Wunderink

Research output: Contribution to journalShort survey

80 Citations (Scopus)

Abstract

Despite many advances in medical science, the mortality rate from community-acquiredpneumonia (CAP) has changed little in the past four decades. Death and adverse outcomes from CAP result from a complex interplay between the pathogen and the host. Newer information about the effect of pneumonia on comorbidity and underlying diseases, especially long term, suggests this is an important additional axis that differs from the traditional triangular concept of pathogen, host defense, and antibiotic treatment. A number of clinical scoring systems have been developed to help physicians identify patients with CAP at risk of adverse outcomes. None of the criteria have been prospectively demonstrated to avoid late intensive care unit transfers or lower mortality, raising interest in the use of biomarkers such as procalcitonin. Quantitative bacterial genomic load represents a potentially important risk stratification. Optimal antibiotic management appears to include use of a macrolide, although the mechanism of benefit remains unclear. Attempts to improve CAP outcomes through setting measurable process of care standards are to be applauded, but making sure that these standards do not become the end in themselves, but rather that the entire process of care is improved, remains critical.

Original languageEnglish (US)
Pages (from-to)157-164
Number of pages8
JournalAmerican journal of respiratory and critical care medicine
Volume183
Issue number2
DOIs
StatePublished - Jan 15 2011

Fingerprint

Pneumonia
Anti-Bacterial Agents
Mortality
Bacterial Load
Macrolides
Calcitonin
Standard of Care
Intensive Care Units
Comorbidity
Biomarkers
Physicians
Therapeutics

Keywords

  • Antibiotics
  • Biomarkers
  • Intensive care unit
  • Pneumonia
  • Process of care

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

@article{bb64cb1d0f8941d48fa4ace1739c53ea,
title = "Management of community-acquired pneumonia in adults",
abstract = "Despite many advances in medical science, the mortality rate from community-acquiredpneumonia (CAP) has changed little in the past four decades. Death and adverse outcomes from CAP result from a complex interplay between the pathogen and the host. Newer information about the effect of pneumonia on comorbidity and underlying diseases, especially long term, suggests this is an important additional axis that differs from the traditional triangular concept of pathogen, host defense, and antibiotic treatment. A number of clinical scoring systems have been developed to help physicians identify patients with CAP at risk of adverse outcomes. None of the criteria have been prospectively demonstrated to avoid late intensive care unit transfers or lower mortality, raising interest in the use of biomarkers such as procalcitonin. Quantitative bacterial genomic load represents a potentially important risk stratification. Optimal antibiotic management appears to include use of a macrolide, although the mechanism of benefit remains unclear. Attempts to improve CAP outcomes through setting measurable process of care standards are to be applauded, but making sure that these standards do not become the end in themselves, but rather that the entire process of care is improved, remains critical.",
keywords = "Antibiotics, Biomarkers, Intensive care unit, Pneumonia, Process of care",
author = "Waterer, {Grant W.} and Jordi Rello and Wunderink, {Richard G}",
year = "2011",
month = "1",
day = "15",
doi = "10.1164/rccm.201002-0272CI",
language = "English (US)",
volume = "183",
pages = "157--164",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

Management of community-acquired pneumonia in adults. / Waterer, Grant W.; Rello, Jordi; Wunderink, Richard G.

In: American journal of respiratory and critical care medicine, Vol. 183, No. 2, 15.01.2011, p. 157-164.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Management of community-acquired pneumonia in adults

AU - Waterer, Grant W.

AU - Rello, Jordi

AU - Wunderink, Richard G

PY - 2011/1/15

Y1 - 2011/1/15

N2 - Despite many advances in medical science, the mortality rate from community-acquiredpneumonia (CAP) has changed little in the past four decades. Death and adverse outcomes from CAP result from a complex interplay between the pathogen and the host. Newer information about the effect of pneumonia on comorbidity and underlying diseases, especially long term, suggests this is an important additional axis that differs from the traditional triangular concept of pathogen, host defense, and antibiotic treatment. A number of clinical scoring systems have been developed to help physicians identify patients with CAP at risk of adverse outcomes. None of the criteria have been prospectively demonstrated to avoid late intensive care unit transfers or lower mortality, raising interest in the use of biomarkers such as procalcitonin. Quantitative bacterial genomic load represents a potentially important risk stratification. Optimal antibiotic management appears to include use of a macrolide, although the mechanism of benefit remains unclear. Attempts to improve CAP outcomes through setting measurable process of care standards are to be applauded, but making sure that these standards do not become the end in themselves, but rather that the entire process of care is improved, remains critical.

AB - Despite many advances in medical science, the mortality rate from community-acquiredpneumonia (CAP) has changed little in the past four decades. Death and adverse outcomes from CAP result from a complex interplay between the pathogen and the host. Newer information about the effect of pneumonia on comorbidity and underlying diseases, especially long term, suggests this is an important additional axis that differs from the traditional triangular concept of pathogen, host defense, and antibiotic treatment. A number of clinical scoring systems have been developed to help physicians identify patients with CAP at risk of adverse outcomes. None of the criteria have been prospectively demonstrated to avoid late intensive care unit transfers or lower mortality, raising interest in the use of biomarkers such as procalcitonin. Quantitative bacterial genomic load represents a potentially important risk stratification. Optimal antibiotic management appears to include use of a macrolide, although the mechanism of benefit remains unclear. Attempts to improve CAP outcomes through setting measurable process of care standards are to be applauded, but making sure that these standards do not become the end in themselves, but rather that the entire process of care is improved, remains critical.

KW - Antibiotics

KW - Biomarkers

KW - Intensive care unit

KW - Pneumonia

KW - Process of care

UR - http://www.scopus.com/inward/record.url?scp=78751682782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751682782&partnerID=8YFLogxK

U2 - 10.1164/rccm.201002-0272CI

DO - 10.1164/rccm.201002-0272CI

M3 - Short survey

VL - 183

SP - 157

EP - 164

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -